Search

Your search keyword '"Furrer HJ"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Furrer HJ" Remove constraint Author: "Furrer HJ"
32 results on '"Furrer HJ"'

Search Results

1. Why do sub‐Saharan Africans present late for HIV care in Switzerland?

2. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

3. Combination antiretroviral therapy and duration of pregnancy

4. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

5. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

6. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

7. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

8. Human immunodeficiency virus-specific T lymphocyte cell

11. A Longitudinal Analysis of Healthcare Costs after Treatment Optimization following Genotypic Antiretroviral Resistance Testing: Does Resistance Testing pay off?

12. Long-Term Virological Response to Multiple Sequential Regimens of Highly Active Antiretroviral Therapy for HIV Infection

13. Effect of Individual Cognitive Behaviour Intervention on Adherence to Antiretroviral Therapy: Prospective Randomized Trial

14. Impact of Genotypic Resistance Testing on Selection of Salvage Regimen in Clinical Practice

15. Drug Resistance Mutations in HIV-1-Infected Subjects during Protease Inhibitor-Containing Highly Active Antiretroviral Therapy with Nelfinavir or Indinavir

16. Coping with an HIV infection. A multicenter qualitative survey on HIV positive adolescents' perceptions of their disease, therapeutic adherence and treatment

17. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

18. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

19. Hepatitis A vaccines and the elderly.

20. [The genetics HIV cohort of the Swiss HIV Cohort Study--facing the new challenges in medicine].

21. [Opportunistic diseases in HIV infection].

22. [Respiratory tract viruses].

23. [Antiviral therapy and resistance formation exemplified by HIV infection].

24. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.

25. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

26. Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

27. [Epidemiology of HIV-1 infection in Bern--application of molecular methods].

28. [Prevention of malignant skin tumors].

29. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

30. Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS.

31. Efficacy and tolerance of a miconazole-benzoyl peroxide cream combination versus a benzoyl peroxide gel in the topical treatment of acne vulgaris.

32. [Exogenous light protection].

Catalog

Books, media, physical & digital resources